Asthma control in NYUBAR groups (N = 471).
收藏数据链接：
官方服务：
资源简介：
Data missing for daytime symptoms on 1 subject, nocturnal symptoms in 2 subjects, SABA use in 15 subjects, functional status on 12 subjects.†Only 2 subjects used omalizumab: 1 in Group 2 and 1 in Group 3.*Non-ICS controller includes theophylline, leukotriene inhibitors, cromolyn and LABA.**other controller includes theophylline, leukotriene inhibitors, and cromolyn.
创建时间：
2015-12-02
